In melanoma models, combination therapy with VSV-GP and dendritic cell (DC) vaccines increased CD8+ T cell infiltration, reduced regulatory T cells, and enhanced survival, indicating that immune modulation, rather than direct lysis, contributed to efficacy [37]. The gene discussed is CD8A; the disease is melanoma.